An evaluation of doxorubicin, rapamycin and combinations thereof in drug-eluting beads using in vitro and in vivo HepG2 liver cancer models.

Activity: Talk or presentation typesOral presentation

Period10 Sep 201012 Sep 2010
Event titleFourth International Liver Cancer Association Conference
Event typeConference
LocationMontreal, Canada
Degree of RecognitionInternational